Proper development of the nervous system requires that a carefully controlled balance be maintained between both proliferation and neuronal survival. The process of programmed cell death is believed to play a key role in regulating levels of neuronal survival, in large part through the action of antiapoptotic proteins, such as Bcl-2. Consistent with this, Bcl-2 has been shown to be a key regulator of apoptotic signaling in post-mitotic neurons. However, we still know remarkably little regarding the role that Bcl-2 plays in regulating the survival of specific motor neuron populations. In the present study, we have examined somatic motor neurons of the lumbar spinal cord, and branchiomotor neurons of the facial nucleus in bcl-2-null mice to determine the differential dependence among motor neuron populations with respect to Bcl-2-mediated survival. Examination of neuronal and axon number, axonal area, and the distribution of axonal loss in bcl-2-null mice demonstrates that, in contrast to the great majority of alpha motor neurons, gamma motor neurons exhibit a unique dependence upon bcl-2 for survival. These results demonstrate, for the first time, the connection between Bcl-2 expression, motor neuron survival, and the establishment of different motor populations.
Within the central nervous system (CNS), more post-mitotic neurons are produced than are ultimately incorporated into the mature synaptic architecture. 1 In the motor system, this is believed to, in part, reflect competition among developing neurons for limited levels of neurotrophic support.
1,2 Neurons failing to achieve optimal innervation are in turn eliminated during the latter embryonic and early postnatal periods. 1 Numerous studies have demonstrated the critical role which programmed cell death (PCD) plays in this process. 3 While many stimuli have been shown to be capable of initiating PCD, the core components of this process have been shown to be highly conserved among species as divergent as Caenorhabditis elegans and human. In mammals, two core PCD pathways, termed the extrinsic and intrinsic pathways, have been identified. 4 A major point of convergence between these pathways exists at the mitochondria. It is here, that interaction between pro-and antiapoptotic Bcl-2 family members determines subsequent PCD progression through permeabilization of the mitochondrial outer membrane, inducing both caspase-dependent and caspase-independent signaling. 5, 6 Bcl-2 is the prototypical antiapoptotic Bcl-2 family member, a family that includes Bcl-x L , Bcl-w, Mcl-1, A1, Blf-1, boo/diva, Nr-13, and Ced-9. 7 While questions remain regarding the precise mechanism by which they inhibit PCD, evidence suggests that interference with the oligomerization and/or conformational activation of proapoptotic proteins, such as Bax and Bak is critical. 8 Bcl-2 is also known to interact with components of the mitochondrial permeability transition pore, which is minimally comprised of voltage-dependent anion channel, adenine nucleotide translocase, and cyclophilin D to alter mitochondrial membrane potential. 9 Because of these varied functions, and results from previous knockout and overexpression studies in vivo, Bcl-2 has been identified as a key PCD regulator within both developing and postnatal neurons in mammals. 3 During development, Bcl-2 and Bcl-x L in particular, are widely expressed within the CNS both during and following neurogenesis. [10] [11] [12] Consistent with this, both proteins are thought to play a role in regulating naturally occurring cell death (NOCD). The expression pattern of these antiapoptotic proteins differs, however, with respect to latter development. Bcl-x L continues to be widely expressed in many regions of the postnatal CNS, whereas bcl-2 expression declines in many CNS regions postnatally. 10, [12] [13] [14] However, some neuronal populations do maintain bcl-2 expression postnatally. These include neurons of the sympathetic and sensory ganglia, 12, 15, 16 granule cells of the cerebellum and dentate gyrus, 10 branchiomotor neurons, 15 and motor and interneurons of the spinal cord. 12, 14, 15, 17 With respect to motor neurons, a previous study has suggested that differential sensitivity to bcl-2 deletion may exist within branchiomotor neurons of the facial nucleus. 15 Several independent lines of bcl-2-null mice have been generated previously, eliminating either the bcl-2a 18 or bcl-2a/b 15, 19 transcripts. Each of these lines shows essentially identical phenotypes. Bcl-2-null mice have been shown to exhibit a reduced growth rate, reduced lifespan (largely due to polycystic kidneys), reduced T-cell lifespan, craniofacial anomalies, and hair graying during the second follicle cycle. 15, 18, 19 With respect to the CNS, no gross developmental anomalies have been described. Bcl-2-null mice have been shown to exhibit some developmental loss of sensory, sympathetic, and branchiomotor neurons during the early postnatal period. 15 Similarly, some postnatal loss of retinal ganglion cells has been observed in bcl-2-null mice between P10 and P15, beyond the period of NOCD. 20 In vitro analyses of sympathetic and trigeminal neurons have suggested a role for Bcl-2 in NOCD. 16, 21 With respect to effects on injuryrelated survival, in vivo transection of both the optic 22 and facial 15 nerves shows no difference in survival in bcl-2-null mice versus controls. Similarly, bcl-2-null mice exhibit no difference compared to controls in either neurotrophinmediated survival in vitro 21 or following acute injury. 15 In order to determine the effects of Bcl-2 deficiency on various motor neuron populations in vivo, we have examined the properties of lumbar motor neurons of the spinal cord and branchiomotor neurons of the facial nucleus in several strains of bcl-2-null mice. The results demonstrate for the first time that Bcl-2 plays a unique and critical role in the survival of gamma motor neurons generated during the latter part of neurogenesis.
Results
Bcl-2 differentially regulates the survival of spinal motor neurons. To examine the effect of Bcl-2 deficiency on lumbar spinal motor neurons, total counts of motor neurons were performed on choline acetyltransferase (ChAT) and Nissl-stained serial sections. To first determine those spinal levels which contribute motor axons to the sciatic nerve in bcl-2-null mice and controls, retrograde tracing of sciatic nerves was performed for each genotype. As shown in Figure 1a and b, bcl-2-null mice exhibit a comparable distribution of lumbar spinal motor neurons with respect to both rostral-caudal and intralaminar distribution, respectively, compared to control littermates. As shown in Figure 1c , comparisons of ChAT-positive motor neurons from sciatic levels T13-L2 demonstrate that bcl-2-null mice exhibit a significant reduction (26 ± 3%) in total motor neuron number at postnatal day 30 (P30) compared to control littermates. Counts of spinal motor neuron number performed on additional (alternate) Nissl-stained sections demonstrated comparable levels of motor neuron loss, indicating that bcl-2 ablation does not affect ChAT expression. These results demonstrate that bcl-2 deficiency results in the loss of a sub-population of sciatic motor neurons.
To examine the pattern of Bcl-2 expression within spinal motor neurons, spinal cord sections through the sciatic motor pool were stained for Bcl-2 in the early postnatal period. As shown in Figure 2a -c, a minor population of motor neurons exhibited persistent expression of Bcl-2 postnatally. Stereotactic analysis of wild-type mice within sciatic spinal levels indicated that 32±8% of motor neurons within this region expressed Bcl-2 postnatally.
To better understand the nature of the motor neuron loss seen in bcl-2-null mice, 1 mm thin sections were cut through the L4 ventral roots of bcl-2
, and bcl-2 þ / þ mice at P30. As shown in Figure 3a and b, within the L4 ventral root, total axon counts demonstrated that bcl-2-null mice exhibited a small but significant reduction in axon number compared to littermate controls, despite no significant reduction in total nerve area. Interestingly, the percent reduction in axon number (24±2%) seen in bcl-2-null mice was similar to that observed for spinal motor neurons expressing Bcl-2 postnatally. . N ¼ 7 and 6 for bcl-2 ( þ /À) and (À/À) groups, respectively. Note that with respect to total L4 ventral root area, groups did not significantly different from one another (P ¼ 0.14). (b) Total axon numbers within the L4 ventral root. N ¼ 7 and 6 for ( þ /À) and (À/À) groups, respectively. S.E.M. equal to 15 and 16 for ( þ /À) and (À/À) groups, respectively. Asterisk denotes significant difference from control group at Po0.01. To examine this relationship in greater detail, the distribution of axon cross-sectional areas was determined in entire cross-sections of L4 ventral roots. Individual axon crosssectional areas were determined rather than the standard practice of measuring axon diameter, due to its inherently greater reliability. As shown in Figure 3c and d, bcl-2-null mice exhibit a preferential loss of small caliber axons (p3 mm 2 ). The percent loss of small caliber axons was 61 ± 2% compared to a 12±3% reduction in larger (43 mm 2 ) caliber axons in bcl-2-null mice. Analysis of L4 ventral roots, as shown in Figure 3e and f, demonstrated that bcl-2 À/À mice exhibit a dramatic reduction in small caliber axons compared to heterozygous bcl-2 littermates. The extent of this axonal reduction (24 ± 2%) strongly correlated with the magnitude of the reduction in ChAT-positive neurons (26±3%) seen in sciatic spinal levels, and the population of motor neurons expressing Bcl-2 postnatally (32 ± 8%). These data indicate that the loss of motor axons seen in bcl-2-null mice occurs as a consequence of motor neuron death.
Previous studies have suggested that the neuronal loss resulting from the ablation of bcl-2 occurs during the late embryonic/early postnatal periods, with neuronal reductions stabilizing around P9. 15 To determine whether this pattern was also observed in our lineages of bcl-2 mice, bcl-2-null mice and controls were examined at P10. Counts of L4 ventral roots at P10 indicated an 18±2% reduction in bcl-2-null mice compared to controls (axon means: 694 ± 11 versus 848 ± 9 for controls).
Reduction of muscle spindle innervation and sensory losses in bcl-2-null mice. The loss of small caliber motor axons seen in bcl-2-null mice indicated that gamma motor neurons are uniquely sensitive to developmental ablation of Bcl-2. As a result, we examined the fusimotor innervation of muscle spindles. As this structure also receives sensory innervation, sensory axons were also examined in bcl-2-null mice. As shown in Figure 4a and b, both nerve area and axon number were reduced within the dorsal root ganglion (DRG) by 28 ± 9 and 27 ± 2%, respectively, suggesting that bcl-2 À/À mice undergo a significant loss of sensory neurons within the DRG by P30. Consistent with this, prior analysis of the L3 DRG in the bcl-2
À/À mice has demonstrated significant neuronal loss at P9. 15 To more clearly define the effects of sensory and motor axon reduction on muscle spindles, the number and morphology of muscle spindles were examined in bcl-2-null mice. Total numbers of muscle spindles were determined in serial cross-sections of both forelimb (flexor carpi ulnaris) and hindlimb (soleus) muscles. At both sites, spindle number did not differ significantly between genotypes. Similarly, the cross-sectional area of intrafusal (bag 2 ) fibers, or adjacent extrafusal (skeletal) muscle fibers of bcl-2 À/À and bcl-2
, n ¼ 80 fibers per genotype). To determine the level of fusimotor innervation of muscle spindles in bcl-2 À/À mice, soleus muscle spindles were cut through both the central (capsular) and terminal regions. As shown in Figure 4c , soleus muscle spindles from bcl-2 heterozygous and wild-type mice receive innervation from multiple fusimotor axons, while spindles from bcl-2 À/À mice are typically innervated by only a single apparent motor (Figure 4d ). Counts of total fusimotor fibers within the soleus muscle indicate a significant decrease in fusimotor innervation in bcl-2 À/À mice versus controls (15±4 versus 80 ± 6). Thus, while bcl-2-null mice exhibit a substantial loss of fusimotor innervation, some residual motor innervation to muscle spindles remained in these animals. Consistent with this, esterase activity is observed within at least some muscle spindles in bcl-2-null mice (data not shown). This innervation may represent the influence of either a small population of surviving fusimotor fibers or collateral sprouting from existing alpha motor fibers (beta innervation). This residual motor innervation may explain the absence of gross dystonia or ataxia seen in bcl-2-null mice. Examination of soleus muscle termini in bcl-2-null mice also demonstrated the presence of normal golgi tendon organs.
Role of bcl-2 in PCD in the facial nucleus. To compare the results observed in spinal motor neurons, branchiomotor neurons of the facial nucleus were examined in bcl-2-null mice. This population was chosen for analyses both because it lacks significant gamma motor innervation 23 and because it has been examined previously in lines of bcl-2-null mice. 15 In addition, we wished to examine motor neuron survival within lateral components of the facial nucleus, as these have previously been suggested to undergo preferential degeneration in bcl-2-null mice. To analyze the lateral (nasolabial) component of the facial nucleus, a retrograde tracer was injected into the medial facial nerve (MFN) (Figure 5a ) to examine this sub-population within the facial nucleus proper (overview, Figure 5b ) for each genotype. As shown in Figure 5c and d, motor neurons, which innervate the MFN, reside within the lateral portion of the facial nucleus. Retrograde labeling of the MFN in bcl-2-null mice demonstrated no significant difference in motor neuron distribution compared to control littermates. It should be noted, however, that a small group of motor neurons at the extreme lateral extent of the facial nucleus was not labeled following MFN injection in any of the genotypes examined.
To determine the overall impact of bcl-2 deletion on facial motor neurons, total counts of motor neurons within the facial nucleus were performed in P30 bcl-2-null mice and controls. As shown in Figure 5e , our lineages of bcl-2-null mice exhibited a reduction of 21±2% in facial motor neurons compared to controls. Interestingly, it has previously been suggested that bcl-2-null mice exhibit an enhanced degeneration of motor neurons within the lateral component of the facial nucleus. 15 To investigate this in our lines of bcl-2-null mice, cross-sectional area, total axon number, and distribution of axon calibers within the MFN were determined for bcl-2-null mice and controls. As shown in Figure 6a and b, bcl-2-null mice exhibited a reduction in both total axon number (15 ± 3%) and mean cross-sectional area (39 ± 6%) compared to controls at P30. In addition, the distribution of axon calibers was shifted toward smaller axon sizes in bcl-2-null mice compared to controls (Figure 6c and d) . Axons within the MFN having cross-sectional areas p3 mm 2 represent 49±6% of the total axon population in bcl-2-null mice, whereas this group represents only 21 ± 11% of the total axon population in bcl-2 heterozygous or wild-type littermates. Given that the facial motor neurons exhibited a total reduction of 21±2% and counts of retrogradely labeled (MFN) lateral facial neurons showed a reduction of only 17 ± 3% (1359 ± 42 versus 1643±73 for controls, n ¼ 5 animals per genotype) in bcl-2-null mice versus controls at P30, these data suggest that motor neurons with the lateral facial nucleus do not exhibit a differential sensitivity to bcl-2 ablation; in contrast to previous findings at P28. 15 
Discussion
To determine the effect of bcl-2 deletion on motor neuron survival, we have examined two motor populations that differ þ / þ mice demonstrate equivalent motor representations between genotypes. Analysis of total axon crosssectional areas within L4 ventral roots demonstrate that the axonal losses observed in bcl-2 À/À animals are not evenly distributed with respect to axon caliber, but disproportionately affect small caliber (p3 mm 2 ) axons, indicating that small (gamma) motor neurons are selectively dependent on Bcl-2. Indeed, in terms of axon classes affected, 68% of the reduction observed in bcl-2-null mice affects axons of areas p3 mm 2 . The predominant loss in small caliber axons seen in bcl-2-null mice corresponds to an extensive reduction in motor innervation (approximately 80%) within muscle spindles as demonstrated from analysis of the soleus muscle. Residual motor input to muscle spindles may represent innervation from either a small number of surviving fusimotor fibers or induced collateral input from adjacent alpha motor neurons (beta fibers innervation).
In addition to spinal motor neurons, similar to a previous report, 15 we observed losses of both branchiomotor and sensory neurons in bcl-2-null mice. However, the degree of neuronal loss we observe in our lineages of bcl-2-null mice on two different genetic backgrounds is somewhat lower (21 ± 2% P30 versus 32% P28 for facial motor neurons; 27 ± 2% P30 versus 44% P44 for sensory neurons). In addition, our analyses of the medial branch of the facial nerve (nasolabial musculature) suggest that this population of facial motor neurons is not differentially sensitive to bcl-2 ablation as reported previously. 15 While the nature of this discrepancy remains unclear, it may be related to genetic differences in the murine backgrounds employed. Such differences are unlikely to be related to minor differences in the age of the animals employed (P30 versus P44), as both studies observed little increase in motor neuron due to bcl-2 deletion death beyond P9.
Within sciatic motor pools, previous analyses 24 and our own studies place the fusimotor representation at approximately 30% of the total motor neuron population. Consistent with these findings, we observe that the population of lumbar spinal motor neurons that strongly express Bcl-2 postnatally is comparable in number to both the degree of motor neuron loss seen in bcl-2-null mice at P30 and the fusimotor representation in this population. Alpha and gamma motor neurons represent two closely related lineages derived from a common neural precursor. 25 Initially, both neural types make similar innervations to primary myofibers. 26 A primary difference between these two motor classes relates to the temporal pattern of their differentiation. 27 The majority of motor neurons differentiate during the early phase of spinal cord development (embryonic day 10-11 in rodents), and primary motor neurogenesis is essentially complete by E14. 28 Alpha motor neurons (and interestingly group Ia sensory neurons, which provide innervation to muscle spindles) differentiate and become established early in this process. By contrast, differentiation of gamma motor neuron (and group II sensory neuron) occurs later, as the earliest known antigenic markers of these populations are observed beginning at E16.5-E17. 27 Thus, it appears (at least within somatic motor pools) that the latter differentiation events of gamma motor neurons set the stage for enhanced dependence upon bcl-2 for survival, in contrast to earlier differentiation for alpha motor neurons. Thus, the differentiation of motor neurons into distinct classes occurs over the same developmental period that motor neuron numbers are principally adjusted through the process of PCD, from the peak levels of genesis to functional levels seen postnatally. Our results in bcl-2-null mice with spinal cord motor neurons demonstrate that these two processes can be mechanistically linked, guiding the development of specific motor populations in mammals in vivo.
It is interesting to note that ablation of bcl-2 not only influences gamma motor neurons but also results in the loss of a sub-population of alpha motor neurons in both lumbar spinal (12 ± 3% based upon loss of axons 43 mm 2 ) and branchiomotor (21±2% based upon total facial nucleus counts) neurons. It is tempting to speculate that these bcl-2-dependent alpha motor neurons may represent latterdifferentiating members of the population. The concept of a temporal pattern for bcl-2 in regulating neuronal survival is consistent with our observation that neither muscle spindle number (regulated by Ia sensory innervation) nor levels of group Ia innervation within muscle spindles were significantly altered in bcl-2 null compared to controls. Thus, the loss of sensory neurons seen within the DRG of bcl-2-null mice reflects bcl-2-dependent cell death in a class (or classes) of sensory neurons, perhaps group II neurons, which differentiate subsequently to group Ia neurons during embryonic development. 29 The development of muscle spindles is initiated upon the innervation of primary myotubes by proprioceptive (Ia) afferents. 30 Arrival of sensory fibers is sufficient to trigger the differentiation of primary myofibers to early intrafusal (bag 2 ) fibers. 31 It has been shown, at least for muscles of the hindlimb, that limiting concentrations of neurotrophin-3 (NT-3) produced within the developing myofibers regulate the outgrowth of these proprioceptive axons from the DRG to muscle spindles. 32 As development proceeds, expression of NT-3 becomes restricted to intrafusal fibers within the developing spindle. Motor innervation of the muscle spindle occurs subsequent to the arrival of sensory fibers and the differentiation of the myotube. Consistent with this, survival of fusimotor neurons has been shown to be dependent upon the presence of Ia afferents and/or muscle spindles, as fusimotor neurons are not observed in mice lacking muscle spindles. 27 By contrast, the near or total absence of motor innervation to muscle spindles does not prevent their differentiation or maintenance. 27, 33 This model is supported by our present work in bcl-2 À/À mice, in which the loss of a substantial portion of fusimotor innervation did not significantly alter the number of muscle spindles within the hindlimb.
In support of the model in which bcl-2 differentially regulates the survival of gamma motor neurons, examinations of several lines of genetically modified mice that lack or overexpress factors known to act through Bcl-2 (bax and ntf3 null mutants, gdnf heterozygous mutants, MyoGDNF transgenic mice) exhibit significant differences in their gamma population. [34] [35] [36] That gamma motor neurons require glial cell line-derived neurotrophic factor (GDNF) for survival derived from muscle spindles is suggested from studies in which significant losses of small diameter motor axons are observed in gdnf heterozygous animals. Similarly, transgenics ectopically expressing GDNF within skeletal muscle exhibit a substantial increase in small diameter motor axons within the L4 ventral root, 34, 35 although the precise nature of the motor neurons contributing these axons is unclear. Analysis of the L4 ventral root in bax null mice reveals a significant increase in total numbers of myelinated axons, which is contributed exclusively by small diameter axons believed to be derived from gamma motor neurons. 34, 36 The greater relative increase in motor axons in bax null mice (71%) compared to the reductions seen in bcl-2-null mice (24%) likely reflects the greater potential for functional compensation by Bcl-2 homologues (Bcl-x L , Mcl-1, Bcl-w, etc.) compared to Bax homologues (Bak, Bok, etc.) for motor neuron survival. Interestingly, it was also demonstrated that a substantial population of unmyelinated axons was rescued by bax deletion. 34, 37 While the ventral roots of adult wild-type mice normally contain very low numbers of unmyelinated axons, this is also true for our lineages of bcl-2-null mice (Supplementary Figure 1 ). Given the model proposed for bcl-2, and the nature of interactions between Bcl-2 and Bax, this finding is not surprising and paints a consistent picture of Bcl-2's action. Based upon the results in bcl-2-null mice, the mechanisms by which neurotrophic agents such as NT-3 and GDNF exert control over the development of specific motor populations, such as fusimotor neurons (and potentially alpha subgroups), can be clearly framed in a broader understanding of their influence by bcl-2/bax interactions to regulate the process of PCD.
Materials and Methods Animals. Bcl-2-null mice derived from two independent gene-targeting events ('bcl2DL', B13, and 'bcl2SK' Z3 -Jackson Labs) were obtained from the appropriate heterozygous intercrosses. The genotypes of all bcl-2 animals were confirmed by Southern blot analysis of genomic tail DNA or by PCR as described previously. 19 Mice were raised under identical conditions in the same room of our animal facility, and killed for examination from P10 to P30. All experimental protocols conformed to Mount Sinai Hospital and University of Toronto animal colony care guidelines.
To assess the potential contribution of genetic background on any effects observed in bcl-2-null mice, two sublines of the initial 'bcl2DL' (mixed 129Sv: C57bl/ 6 background) stock were established through back-crossing onto either 129Sv/Cp (four generations) or C57BL/6J (five generations) to generate sublines 'bcl2DL-129' and 'bcl2DL-C57'. The results described obtained from comparative groups of wildtype, heterozygous, or bcl-2-null mice did not vary significantly from either of the sublines or comparative bcl2SK mice. The data shown in the paper represent data from bcl-2 homozygous or heterozygous littermates derived from C57BL/6J intercrosses (bcl2DL-C57 mice).
Retrograde tracing. P30 animals were anesthetized by intraperitoneal injection of a freshly prepared 2.5% solution of Avertin, at a dose of 0.2 ml per 10 g body weight. Following the removal of overlying hair, a surgical incision was made in the skin and underlying fascia, and the desired nerve isolated. Following isolation of the nerve from surrounding tissue, a 5% solution of rhodamine dextran or Fast DiI (Molecular Probes) was pressure-injected into the indicated nerve (250 nl) over a period of 3 min. For sciatic nerves, the injection placement was 3 mm distal to the obdurator tendon. For facial nerves, the position of injection within the MFN is shown in Figure 5a . Following injection, incisions were closed with 6.0 sutures and animals were allowed to recover for 48 h, at which time they were killed and the appropriate tissues processed as indicated below.
Tissue preparation and analysis. Animals were deeply anesthetized with sodium pentobarbital (Somnitol, 80 mg/kg) and perfused transcardially with 15 ml of 100 mM phosphate-buffered saline (PBS, pH 7.4), followed immediately by 50 ml of freshly prepared 4% paraformaldehyde in PBS at 41C. A 2-mm segment of the MFN was dissected and prepared as indicated below, as were muscles of the upper (flexor carpi ulnaris) and lower limbs (soleus and medial gastrocnemius). Whole brains were removed and the brainstem isolated from each animal. The spinal column corresponding to segments T12-L4 was exposed and isolated. Samples were subsequently post-fixed for a further 4 h in 4% paraformaldehyde in PBS at 41C. At this point, the T12-L3 segment of the spinal cord, and the L4 dorsal and ventral roots were dissected out from each specimen. Spinal cords were processed for either cryostat or paraffin sections according to standard procedures. 38 Spinal roots and muscle were processed as indicated below. Following processing, each sample block was given a coded identification number, so that data derived could be analyzed in a blinded manner.
For stereotactic analyses, brainstems containing the facial nucleus and the entirety of the T13-L2 segments of the lumbar spinal cord were processed as serial sets of 7 mm paraffin sections. Following de-waxing, sections were stained with 0.1% thionin, dehydrated and mounted according to standard procedures. Facial motor counts were performed on every sixth section and total motor neuron numbers were assessed by the method of physical dissector (frame interval ¼ 42 mm). 39 For counts of spinal cord ChAT-positive neurons and Nisslstained series (see below), the T13-L2 levels of spinal cords were isolated and cut as serial sets of 30 mm cryostat sections. Total numbers of ChAT-positive motor neurons within the anterior horn were then evaluated at 300 mm intervals (n ¼ 4 animals per genotype). In addition, these sections were stained with 1 mg/ml bisbenzamide (Hoechst 33258) to clarify the nuclei and nucleoli of motor neurons. Alternate sections in each series were stained with 0.1% thionin to compare Nissl counts of motor neuron number to those obtained with ChAT staining. For Nissl and ChAT series, no significant systematic variation in spinal motor neuron counts was observed between Nissl and ChAT, and hence only counts of ChAT-positive motor neurons are described herein. For all analyses, numeric counts were not corrected for split nucleoli. Statistical significance was assessed as indicated below (Statistical methods).
Thin sections. Nerve segments and muscle spindle samples were post-fixed in a solution of freshly prepared 2.5% glutaraldehyde in 100 mM PBS (pH 7.4) for 4 h at 41C; and rinsed free of glutaraldehyde and fixed in 1% osmium tetroxide buffered in PBS for 1 h. Samples were dehydrated in a series of water/ethanol and ethanol/ propylene oxide baths. Following removal of propylene oxide, samples were embedded in spurr resin and baked at 501C for 36 h. A series of 1 mm crosssections were then obtained and stained with 1% toluidine blue according to standard procedures. 38 For spinal roots, thin sections were obtained at the point midway between the attached DRG and the spinal end of the nerve.
Histochemistry/immunohistochemistry. Following 3 h of post-fixation at 41C, spinal cords and isolated muscles were placed in a solution of 30% sucrose and 0.1 M PBS (pH 7.4) at 41C until equilibrated (12-15 h) and then frozen in 2-methyl butane at À201C. Serial sets of 10-30 mm cross-sections were obtained using a Reichardt-Jung Fridgocut cryostat at À221C. Sections were mounted onto 2 Â gelatin-stubbed slides. Serial cryostat or microtome sections were stained with 0.1% thionin or processed for ChAT immunohistochemistry, using a goat anti-ChAT antibody (Chemicon AB144). For ChAT sections, peroxidase activity was first inhibited by incubating sections for 30 min in a solution of 100% methanol/3% hydrogen peroxide. Nonspecific antibody binding was blocked by pre-incubation in 5% normal goat serum and 0.2% Tween-20 in PBS, pH 7.4, for 1 h at room temperature. Primary antibody was added at a dilution of 1 : 800 and sections were incubated overnight at 41C. Following washing, sections were incubated with biotinylated secondary antibody at a dilution of 1 : 200 for 2 h at room temperature followed by incubation with streptavidin-HRP at 1 : 100 for 1 h at room temperature (Vectastain ABC kit, PK-4005). Bcl-2 expression was detected by immunofluorescence using mouse anti-Bcl-2 antibody (DAKO M0887 1 : 20). Motor neurons were distinguished using anti-Islet-1/2 (1 : 1000) generously provided by the laboratory of Thomas Jessell. Fluorescent secondary antibodies (1 : 200) used were purchased from Molecular Probes.
Analysis of axon/nerve morphometry. The morphometry of nerve and muscle cross-sections were analyzed using a Leitz-Wetzlar microscope equipped with 25, 54, and 100 times objectives, a JVC model TK-1280U color video camera, and a 3601 rotating slide platform equipped with X and Y controllers. Axon and nerve areas were measured using a Leica Quantimet Q500MC system (Leica Canada, Willowdale, ON, Canada). The system was calibrated before and verified following each use using a Leica 10 mm ruled calibration slide. Prior to analyzing each cross-section, a low-resolution (25 Â ) map was first generated and a hardcopy printed. This was used as a reference to place each of the individual nerve (analyzed at 100 Â ) or muscle (analyzed at 40 Â ) sectors in a given morphometric analysis. In each case, data were gathered for the nerve cross-section in its entirety, and sample data were coded and analyzed in a double-blinded manner.
Statistical methods. Statistical analyses were performed using Graphpad PRISM. Assessment of difference between means was determined by unpaired, two-tailed parametric Student's t-test with assumption of unequal variance. Null hypotheses were rejected at the 0.01 level. Results are expressed as mean±S.E.M. and were thus determined to be significant if Po0.01.
